Moby Sells You the Buy. It Leaves You the Hardest Part.

You're holding a pitch you've heard before, aimed straight at you: pay about $99 and a team of ex–Goldman and ex–Morgan Stanley analysts will hand you stock picks that, the marketing says, beat the market every year since 2020. The app is Moby, a subscription research app with over thirty million users, and its landing page promises the "institutional-grade" research a retail investor can't otherwise get. The natural reaction is relief: an edge, pre-packaged, for the price of a pair of sneakers.

Here is the mental picture most people carry when they read that, and the part it deletes: that a printed track record, plus a big user count, means the picks actually work. Follow that belief and the expensive version of it is that you stop doing your own vetting, hand your buying decisions to a list, and assume the hard thinking has been done for you. It hasn't been. It has been priced and sold.

Start with an older business that does the same thing with horses. A man in a loud jacket sells tip sheets outside the track: $20 for tomorrow's picks, and look—last year I called the 40-to-1 shocker and the plodding filly that closed like Secretariat. He gets paid whether you win or lose, which is precisely why he only needs you to buy next week's sheet. He shows you the winners and never the two hundred losers. And he never mentions two decisions that decide your money: which of his picks to actually bet, and exactly when to cash out. Delete those two steps and the tout's genius is entirely self-reported.

Now label the props. The tip sheet is Moby's weekly picks. Last year's glowing names are the Nvidia and Tesla calls the app's marketing resurrects. The tout's fee is the subscription, collected whether or not your account grows. And the missing page—when to sell—is the one the app genuinely does not give you, which is the crux of the whole business. Independent reviews of Moby, current into 2026, say the same thing in plain English: the service issues buy recommendations but zero guidance on when to sell; one reviewer could only make the picks work in a backtest by bolting on his own 30% stop loss, and noted the CEO suggests selling at the price target.

That alone is the whole surprise, so let's not bury it. The thing that most decides whether a pick becomes your gain or a paper profit that evaporates—the exit—is the exact piece the subscription leaves to you, the person paying precisely because you wanted the thinking done. You've bought the diagnosis. You still have to perform the surgery.

Check one: the denominator doing the heavy lifting

Moby's number that grabs you is the user count. "Over 30 million people use Moby," the app store and site say. That is a reach number—people who have seen the content—and it is doing work it cannot support. The company's own funding materials paint a smaller, more honest picture: roughly 300,000 freemium subscribers and near 100,000 monthly active app users. The figure that finances the business is far smaller still, because in a freemium model most of those people pay nothing.

Now watch the denominator pull a disappearing act. A big number in the headline (users) is swapped in for the number that actually matters (paying customers). The same sleight hides inside "nearly 100,000 market-beating reports." That phrase is a category error: a report cannot beat the market. Only a dollar, invested at a specific price and held over a specific window, can. "Market-beating report" is a unit that measures nothing.

Check two: a track record is a timestamp, not a promise

The headline claim—beat the market every year since 2020—is company-promoted marketing, and it depends on measurement choices you can't see. When did each pick get issued, at what price could you actually have bought, which picks count, and what stops the clock? Independent trackers reach a different, frailer answer. One 2026 review cites an unverified StockAnalysis.com tabulation that Moby's picks beat the S&P 500 by an average of roughly 10.9% with 73% of picks profitable. Another's three-year ranking of newsletters under $500 a year puts Moby fifth, picks up about 39%, roughly 10% over the S&P 500, with 62% of picks profitable—a real but modest edge, and below the leaders it's being sold against.

The showcase numbers work the same way the tout's do. A past winner like Nvidia, "up 991%" from a May 2020 pick, is only yours if you bought on that issue date, at that price, and sold at the peak—and nothing in the service tells you when that peak arrived. Announce the winners in a landscape where nobody audits the dates, and the record reads far better than the live data that trails it.

Check three: who gets paid, and on whose clock

Behind the curtain is a simple commercial fact: Moby is a subscription business, and roughly three-quarters of its revenue comes from subscriptions. The seller is paid whether your portfolio rises or falls, and its growth pitch is precisely "you need my edge"—the identical pitch made by every competitor whose track records contradict each other. A 30-day money-back guarantee refunds your fee, not your losses.

None of this makes Moby a fraud, and it's worth saying so plainly, because the honest version of the analysis is more interesting. Independent reviewers find real research quality, a well-built mobile product, and an edge that, on the live data, is real if slender. The problem is narrower than dishonesty and easier to miss: the "proven edge" is unverifiable in the way that matters to your cash, and the product deliberately withholds the sell decision—the one input that decides whether its edge ever reaches your bank account.

Here is where the tout analogy does its job, and where it breaks. Moby is not a con artist who never published a loser; its losers are published, and the trail shows a modest genuine edge. What survives of the analogy is the incentives: an annual fee around $199, promoted down to $99 for a first year, buys roughly 156 picks, which the marketing helpfully reframes as 64 cents a pick. Divide by the yearly output and it sounds trivial. Multiply the output across a portfolio you must exit yourself and the cheapness evaporates. The clock that always turns is Moby's renewal date. The clock that only turns when you start it is yours.

The test that survives

So before you pay for any pick service, run three checks, and Moby is a fair test case. One: separate the marketing reach (thirty million users) from the paying base and ask which number you actually benefit from. Two: demand a track record with timestamps, fees and holding periods specified, sells included, and an independent audit—and notice that the record that flatters you has none of those features. Three: acknowledge that the seller is paid whether you win or not, and ask what that does to the advice.

The one test I would keep, though, is shorter. A stock-picking subscription that tells you what to buy but not when to sell has sold you only half the decision—and it is the cheaper half. The expensive half, the one that turns a thesis into an outcome, is left on your desk. If you remember one question, use this one: what exactly did I pay for, and is the part I just bought the part that actually makes the money? If the answer is the easy half, the five minutes you just spent reading is a better investment than the $99.